nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—GLYATL1—renal system—cervical cancer	0.0276	0.0276	CbGeAlD
Glycine—GLYAT—renal system—cervical cancer	0.026	0.026	CbGeAlD
Glycine—ALAS2—decidua—cervical cancer	0.02	0.0201	CbGeAlD
Glycine—AGXT—renal system—cervical cancer	0.0178	0.0178	CbGeAlD
Glycine—GPR18—endometrium—cervical cancer	0.0176	0.0176	CbGeAlD
Glycine—GCSH—renal system—cervical cancer	0.0171	0.0171	CbGeAlD
Glycine—ALAS2—female reproductive system—cervical cancer	0.0158	0.0158	CbGeAlD
Glycine—AGXT2—renal system—cervical cancer	0.0151	0.0151	CbGeAlD
Glycine—GPR18—female reproductive system—cervical cancer	0.0146	0.0146	CbGeAlD
Glycine—GLRA2—renal system—cervical cancer	0.0145	0.0145	CbGeAlD
Glycine—GLDC—decidua—cervical cancer	0.0144	0.0144	CbGeAlD
Glycine—GLDC—renal system—cervical cancer	0.0141	0.0141	CbGeAlD
Glycine—PIPOX—uterine cervix—cervical cancer	0.0141	0.0141	CbGeAlD
Glycine—GLDC—endometrium—cervical cancer	0.0137	0.0137	CbGeAlD
Glycine—GCSH—female reproductive system—cervical cancer	0.0137	0.0137	CbGeAlD
Glycine—PIPOX—decidua—cervical cancer	0.0134	0.0135	CbGeAlD
Glycine—GLDC—mammalian vulva—cervical cancer	0.0132	0.0132	CbGeAlD
Glycine—PIPOX—renal system—cervical cancer	0.0132	0.0132	CbGeAlD
Glycine—GPR18—vagina—cervical cancer	0.0132	0.0132	CbGeAlD
Glycine—PIPOX—endometrium—cervical cancer	0.0128	0.0128	CbGeAlD
Glycine—GCSH—female gonad—cervical cancer	0.0124	0.0124	CbGeAlD
Glycine—GCAT—endometrium—cervical cancer	0.0124	0.0124	CbGeAlD
Glycine—PIPOX—mammalian vulva—cervical cancer	0.0123	0.0124	CbGeAlD
Glycine—AGXT2—female reproductive system—cervical cancer	0.0121	0.0121	CbGeAlD
Glycine—ALAS1—uterine cervix—cervical cancer	0.012	0.012	CbGeAlD
Glycine—GCAT—mammalian vulva—cervical cancer	0.012	0.012	CbGeAlD
Glycine—GNMT—female reproductive system—cervical cancer	0.0119	0.012	CbGeAlD
Glycine—ALAS1—decidua—cervical cancer	0.0114	0.0114	CbGeAlD
Glycine—GLDC—female reproductive system—cervical cancer	0.0113	0.0113	CbGeAlD
Glycine—ALAS1—renal system—cervical cancer	0.0112	0.0112	CbGeAlD
Glycine—GARS—uterine cervix—cervical cancer	0.0109	0.0109	CbGeAlD
Glycine—ALAS1—endometrium—cervical cancer	0.0108	0.0109	CbGeAlD
Glycine—ALAS1—mammalian vulva—cervical cancer	0.0105	0.0105	CbGeAlD
Glycine—GARS—decidua—cervical cancer	0.0104	0.0104	CbGeAlD
Glycine—GATM—uterine cervix—cervical cancer	0.0104	0.0104	CbGeAlD
Glycine—GLDC—vagina—cervical cancer	0.0102	0.0102	CbGeAlD
Glycine—GARS—renal system—cervical cancer	0.0102	0.0102	CbGeAlD
Glycine—ALAS1—uterus—cervical cancer	0.00999	0.01	CbGeAlD
Glycine—GATM—decidua—cervical cancer	0.00988	0.00989	CbGeAlD
Glycine—GARS—endometrium—cervical cancer	0.00988	0.00989	CbGeAlD
Glycine—SLC6A9—lymph node—cervical cancer	0.0098	0.00981	CbGeAlD
Glycine—GATM—renal system—cervical cancer	0.0097	0.00971	CbGeAlD
Glycine—PIPOX—female gonad—cervical cancer	0.00961	0.00963	CbGeAlD
Glycine—PIPOX—vagina—cervical cancer	0.00955	0.00957	CbGeAlD
Glycine—GARS—mammalian vulva—cervical cancer	0.00955	0.00957	CbGeAlD
Glycine—SHMT2—uterine cervix—cervical cancer	0.0095	0.00951	CbGeAlD
Glycine—GCAT—female gonad—cervical cancer	0.00932	0.00934	CbGeAlD
Glycine—GCAT—vagina—cervical cancer	0.00927	0.00928	CbGeAlD
Glycine—GARS—uterus—cervical cancer	0.0091	0.00911	CbGeAlD
Glycine—SHMT2—decidua—cervical cancer	0.00905	0.00906	CbGeAlD
Glycine—ALAS1—female reproductive system—cervical cancer	0.00898	0.00899	CbGeAlD
Glycine—GLRB—uterine cervix—cervical cancer	0.0089	0.00891	CbGeAlD
Glycine—SHMT2—renal system—cervical cancer	0.00889	0.0089	CbGeAlD
Glycine—SHMT1—uterine cervix—cervical cancer	0.00865	0.00866	CbGeAlD
Glycine—GATM—uterus—cervical cancer	0.00864	0.00865	CbGeAlD
Glycine—SHMT2—endometrium—cervical cancer	0.00859	0.0086	CbGeAlD
Glycine—GPR18—lymph node—cervical cancer	0.00853	0.00854	CbGeAlD
Glycine—SHMT2—mammalian vulva—cervical cancer	0.00831	0.00832	CbGeAlD
Glycine—GARS—female reproductive system—cervical cancer	0.00818	0.00819	CbGeAlD
Glycine—ALAS1—female gonad—cervical cancer	0.00817	0.00818	CbGeAlD
Glycine—ALAS1—vagina—cervical cancer	0.00812	0.00814	CbGeAlD
Glycine—SHMT1—renal system—cervical cancer	0.00809	0.0081	CbGeAlD
Glycine—GCSH—lymph node—cervical cancer	0.00799	0.008	CbGeAlD
Glycine—SHMT2—uterus—cervical cancer	0.00792	0.00793	CbGeAlD
Glycine—SHMT1—endometrium—cervical cancer	0.00782	0.00783	CbGeAlD
Glycine—GATM—female reproductive system—cervical cancer	0.00777	0.00778	CbGeAlD
Glycine—SHMT1—mammalian vulva—cervical cancer	0.00757	0.00758	CbGeAlD
Glycine—GARS—female gonad—cervical cancer	0.00744	0.00745	CbGeAlD
Glycine—GARS—vagina—cervical cancer	0.0074	0.00741	CbGeAlD
Glycine—SHMT2—female reproductive system—cervical cancer	0.00712	0.00713	CbGeAlD
Glycine—GATM—female gonad—cervical cancer	0.00707	0.00708	CbGeAlD
Glycine—GATM—vagina—cervical cancer	0.00702	0.00703	CbGeAlD
Glycine—SLC36A1—renal system—cervical cancer	0.0069	0.00691	CbGeAlD
Glycine—GLDC—lymph node—cervical cancer	0.00662	0.00663	CbGeAlD
Glycine—GSS—uterine cervix—cervical cancer	0.00649	0.0065	CbGeAlD
Glycine—SHMT1—female reproductive system—cervical cancer	0.00648	0.00649	CbGeAlD
Glycine—SHMT2—female gonad—cervical cancer	0.00648	0.00649	CbGeAlD
Glycine—SHMT2—vagina—cervical cancer	0.00644	0.00645	CbGeAlD
Glycine—GSS—decidua—cervical cancer	0.00619	0.0062	CbGeAlD
Glycine—SLC36A1—uterus—cervical cancer	0.00615	0.00616	CbGeAlD
Glycine—GSS—renal system—cervical cancer	0.00607	0.00608	CbGeAlD
Glycine—GLRB—vagina—cervical cancer	0.00603	0.00604	CbGeAlD
Glycine—GCAT—lymph node—cervical cancer	0.00599	0.006	CbGeAlD
Glycine—SHMT1—female gonad—cervical cancer	0.0059	0.0059	CbGeAlD
Glycine—GSS—endometrium—cervical cancer	0.00587	0.00588	CbGeAlD
Glycine—SHMT1—vagina—cervical cancer	0.00586	0.00587	CbGeAlD
Glycine—GSS—mammalian vulva—cervical cancer	0.00568	0.00569	CbGeAlD
Glycine—SLC36A1—female reproductive system—cervical cancer	0.00553	0.00553	CbGeAlD
Glycine—GSS—uterus—cervical cancer	0.00541	0.00542	CbGeAlD
Glycine—ALAS1—lymph node—cervical cancer	0.00525	0.00526	CbGeAlD
Glycine—GRIN2A—vagina—cervical cancer	0.00503	0.00504	CbGeAlD
Glycine—SLC36A1—female gonad—cervical cancer	0.00503	0.00504	CbGeAlD
Glycine—SLC36A1—vagina—cervical cancer	0.005	0.005	CbGeAlD
Glycine—GSS—female reproductive system—cervical cancer	0.00487	0.00487	CbGeAlD
Glycine—SLC16A10—epithelium—cervical cancer	0.0048	0.0048	CbGeAlD
Glycine—GARS—lymph node—cervical cancer	0.00479	0.00479	CbGeAlD
Glycine—GATM—lymph node—cervical cancer	0.00454	0.00455	CbGeAlD
Glycine—GSS—female gonad—cervical cancer	0.00443	0.00443	CbGeAlD
Glycine—GSS—vagina—cervical cancer	0.0044	0.00441	CbGeAlD
Glycine—SHMT2—lymph node—cervical cancer	0.00416	0.00417	CbGeAlD
Glycine—SLC16A10—mammalian vulva—cervical cancer	0.00416	0.00417	CbGeAlD
Glycine—GLRB—lymph node—cervical cancer	0.0039	0.00391	CbGeAlD
Glycine—SHMT1—lymph node—cervical cancer	0.00379	0.0038	CbGeAlD
Glycine—SLC16A10—female reproductive system—cervical cancer	0.00356	0.00357	CbGeAlD
Glycine—SLC36A1—lymph node—cervical cancer	0.00323	0.00324	CbGeAlD
Glycine—SLC16A10—vagina—cervical cancer	0.00322	0.00323	CbGeAlD
Glycine—GSS—lymph node—cervical cancer	0.00285	0.00285	CbGeAlD
Glycine—SLC16A10—lymph node—cervical cancer	0.00208	0.00209	CbGeAlD
Glycine—SHMT1—Metabolism of folate and pterines—MTHFR—cervical cancer	0.000157	0.113	CbGpPWpGaD
Glycine—SHMT2—One Carbon Metabolism—MTHFR—cervical cancer	0.000108	0.0777	CbGpPWpGaD
Glycine—SHMT2—Trans-sulfuration and one carbon metabolism—MTHFR—cervical cancer	9.66e-05	0.0698	CbGpPWpGaD
Glycine—SHMT2—Vitamin B12 Metabolism—MTHFR—cervical cancer	6.66e-05	0.0481	CbGpPWpGaD
Glycine—SHMT1—One Carbon Metabolism—MTHFR—cervical cancer	6.34e-05	0.0458	CbGpPWpGaD
Glycine—SHMT1—Trans-sulfuration and one carbon metabolism—MTHFR—cervical cancer	5.7e-05	0.0411	CbGpPWpGaD
Glycine—GSS—Trans-sulfuration and one carbon metabolism—MTHFR—cervical cancer	5.55e-05	0.0401	CbGpPWpGaD
Glycine—SHMT2—Folate Metabolism—MTHFR—cervical cancer	5.42e-05	0.0391	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	5.21e-05	0.0376	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—TAAR6—cervical cancer	3.97e-05	0.0287	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—MTHFR—cervical cancer	3.19e-05	0.023	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—WNT2—cervical cancer	3.1e-05	0.0224	CbGpPWpGaD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—TERT—cervical cancer	2.76e-05	0.0199	CbGpPWpGaD
Glycine—SHMT1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	2.56e-05	0.0185	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—WNT5A—cervical cancer	2.35e-05	0.017	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—TAAR6—cervical cancer	2.24e-05	0.0162	CbGpPWpGaD
Glycine—SHMT2—Folate Metabolism—TP53—cervical cancer	2.06e-05	0.0148	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—TAAR6—cervical cancer	2.04e-05	0.0147	CbGpPWpGaD
Glycine—GRIN2C—Alzheimers Disease—CASP8—cervical cancer	1.7e-05	0.0123	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—WNT2—cervical cancer	1.59e-05	0.0115	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—AKAP13—cervical cancer	1.54e-05	0.0111	CbGpPWpGaD
Glycine—GARS—Gene Expression—RARB—cervical cancer	1.53e-05	0.0111	CbGpPWpGaD
Glycine—ALAS2—Metabolism—CA9—cervical cancer	1.4e-05	0.0101	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—AKAP13—cervical cancer	1.4e-05	0.0101	CbGpPWpGaD
Glycine—GRIN2A—Alzheimers Disease—CASP8—cervical cancer	1.3e-05	0.00936	CbGpPWpGaD
Glycine—GRIN2C—Alzheimers Disease—CASP3—cervical cancer	1.28e-05	0.00927	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—TP53—cervical cancer	1.21e-05	0.00875	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—WNT5A—cervical cancer	1.2e-05	0.0087	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TAAR6—cervical cancer	1.2e-05	0.00869	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CA9—cervical cancer	1.06e-05	0.00766	CbGpPWpGaD
Glycine—GATM—Metabolism—CA9—cervical cancer	1.06e-05	0.00766	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CA9—cervical cancer	1.06e-05	0.00766	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CA9—cervical cancer	1.06e-05	0.00766	CbGpPWpGaD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—TP53—cervical cancer	1.05e-05	0.00758	CbGpPWpGaD
Glycine—GARS—Gene Expression—NOTCH2—cervical cancer	1.01e-05	0.00732	CbGpPWpGaD
Glycine—BAAT—Metabolism—CA9—cervical cancer	1.01e-05	0.00731	CbGpPWpGaD
Glycine—GRIN2A—Alzheimers Disease—CASP3—cervical cancer	9.81e-06	0.00708	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—WNT2—cervical cancer	9.39e-06	0.00678	CbGpPWpGaD
Glycine—AGXT—Metabolism—CA9—cervical cancer	9.02e-06	0.00651	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CA9—cervical cancer	8.74e-06	0.00631	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKAP13—cervical cancer	8.25e-06	0.00595	CbGpPWpGaD
Glycine—GRIN2C—Alzheimers Disease—TP53—cervical cancer	8.24e-06	0.00595	CbGpPWpGaD
Glycine—SHMT1—Disease—WNT2—cervical cancer	7.9e-06	0.00571	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CA9—cervical cancer	7.67e-06	0.00554	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—WNT5A—cervical cancer	7.12e-06	0.00514	CbGpPWpGaD
Glycine—GRIN2A—Alzheimers Disease—TP53—cervical cancer	6.29e-06	0.00454	CbGpPWpGaD
Glycine—GARS—Gene Expression—NOTCH1—cervical cancer	6.28e-06	0.00453	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CA9—cervical cancer	6.25e-06	0.00451	CbGpPWpGaD
Glycine—GSS—Metabolism—CA9—cervical cancer	6.09e-06	0.0044	CbGpPWpGaD
Glycine—SHMT1—Disease—WNT5A—cervical cancer	5.99e-06	0.00433	CbGpPWpGaD
Glycine—ALAS2—Metabolism—MTHFR—cervical cancer	5.68e-06	0.0041	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NOTCH2—cervical cancer	5e-06	0.00361	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—MTHFR—cervical cancer	4.3e-06	0.00311	CbGpPWpGaD
Glycine—GATM—Metabolism—MTHFR—cervical cancer	4.3e-06	0.00311	CbGpPWpGaD
Glycine—GLYAT—Metabolism—MTHFR—cervical cancer	4.3e-06	0.00311	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—MTHFR—cervical cancer	4.3e-06	0.00311	CbGpPWpGaD
Glycine—BAAT—Metabolism—MTHFR—cervical cancer	4.11e-06	0.00297	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HES1—cervical cancer	4.1e-06	0.00296	CbGpPWpGaD
Glycine—AGXT—Metabolism—MTHFR—cervical cancer	3.66e-06	0.00264	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TERT—cervical cancer	3.59e-06	0.00259	CbGpPWpGaD
Glycine—ALAS1—Metabolism—MTHFR—cervical cancer	3.54e-06	0.00256	CbGpPWpGaD
Glycine—SHMT1—Disease—HES1—cervical cancer	3.45e-06	0.00249	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FGFR3—cervical cancer	3.29e-06	0.00238	CbGpPWpGaD
Glycine—AGXT2—Metabolism—MTHFR—cervical cancer	3.11e-06	0.00225	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NOTCH1—cervical cancer	3.09e-06	0.00223	CbGpPWpGaD
Glycine—SHMT1—Disease—MTHFR—cervical cancer	3.03e-06	0.00219	CbGpPWpGaD
Glycine—SHMT1—Disease—TERT—cervical cancer	3.02e-06	0.00218	CbGpPWpGaD
Glycine—SHMT1—Disease—FGFR3—cervical cancer	2.77e-06	0.002	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—EGFR—cervical cancer	2.76e-06	0.00199	CbGpPWpGaD
Glycine—SHMT1—Disease—NOTCH1—cervical cancer	2.6e-06	0.00188	CbGpPWpGaD
Glycine—SHMT1—Metabolism—MTHFR—cervical cancer	2.54e-06	0.00183	CbGpPWpGaD
Glycine—GSS—Metabolism—MTHFR—cervical cancer	2.47e-06	0.00179	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MTOR—cervical cancer	2.32e-06	0.00167	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CASP3—cervical cancer	2.13e-06	0.00154	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CTNNB1—cervical cancer	2.05e-06	0.00148	CbGpPWpGaD
Glycine—SHMT1—Disease—MTOR—cervical cancer	1.95e-06	0.00141	CbGpPWpGaD
Glycine—SHMT1—Disease—CD4—cervical cancer	1.95e-06	0.00141	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—STAT3—cervical cancer	1.79e-06	0.00129	CbGpPWpGaD
Glycine—SHMT1—Disease—CTNNB1—cervical cancer	1.73e-06	0.00125	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EGFR—cervical cancer	1.63e-06	0.00118	CbGpPWpGaD
Glycine—SHMT1—Disease—STAT3—cervical cancer	1.51e-06	0.00109	CbGpPWpGaD
Glycine—SHMT1—Disease—EGFR—cervical cancer	1.37e-06	0.000989	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TP53—cervical cancer	1.37e-06	0.000987	CbGpPWpGaD
